Hope is preparing for close-out meetings with the FDA. Chang said the team is “hopeful to advance to a phase 3 confirmatory trial” of the stem cell therapy candidate.

Key Takeaways. TTP following R-CHOP is a strong prognostic factor for survival in R/R DLBCL, with shorter TTP linked to ...

Researchers have shown that glioblastoma can take over the skull marrow to dissolve bone and feed its own growth, suggesting ...

Human ex vivo data validate ABS-201’s potential to reverse follicular miniaturization and drive vellus-to-terminal hair regeneration by demonstrating that it prolongs anagen, stimulates keratin ...

Doctors treating ICU patients on ventilators face a constant challenge regarding nutrition. Now, an AI system can help.

Craif Inc. in Nagoya, Japan, working with Nagoya University's Institute of Innovation for Future Society, has developed a ...

A research team has developed a new hybrid artificial intelligence framework that can accurately estimate leaf nitrogen ...

Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes through targeted T-cell activation.

Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.

An analysis of DNA from millions of individuals has identified shared genetic pathways across psychiatric disorders, findings that could reshape how these conditions are diagnosed and treated.